|
Dyadic International Inc (NASDAQ: DYAI) |
|
Dyadic International Inc
DYAI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Dyadic International Inc growth rates, revenue grew
by 17.62 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 3108
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 12.78 %
Dyadic International Inc net loss increased from $-2 millions, to $-2 millions in first quarter of 2025,
• More on DYAI's Growth
|
|
Dyadic International Inc realized a net loss in trailing twelve months.
Dyadic International Inc realized cash reduction of $ -0.18 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 8.07.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.47.
• More on DYAI's Valuation
|
|
|
|
|
Dyadic International Inc realized net loss in trailing twelve months.
Dyadic International Inc realized cash outflow of $ -0.18per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 8.07.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.47.
Dyadic International Inc Price to Book Ratio is at 31.06 lower than Industry Avg. of 2033.72. and higher than S&P 500 Avg. of 0.01
• More on DYAI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com